Abstract
Properly formulated probiotic-containing foods offer consumers a low risk, low cost dietary component that has the potential to promote health in a variety of ways. Several such products are available commercially, although markets in Japan and Europe are more developed than in the USA. Once healthful attributes of a probiotic product have been identified, there remain microbiological, product, regulatory and labeling issues to be addressed prior to marketing. Microbiological and product issues include safety, effective scale-up for manufacturing, definition of probiotic activity, probiotic stability in the product over the course of product manufacture, shelf-life and consumption, definition of effective dose and target population(s), and development of quality assurance approaches. Examples of probiotic-containing foods are given. Regulatory and labeling issues are complicated because they differ for each country, but are likewise critical because they provide the means for c ommunication of the product benefits to the consumer. The regulatory climate worldwide appears to be one of caution about overstating the benefits of such products but at the same time not preventing corporate commitment to marketing.
Similar content being viewed by others
References
Adams MR & Marteau P (1995) On the safety of lactic acid bacteria from food. Int. J. Food Microbiol. 27: 263-264
Aguirre M & Collins MD (1993) Lactic acid bacteria and human clinical infection. J. Appl. Bacteriol. 75: 95-107
Anon. (1996) Is yogurt the health food it's cracked up to be? Tufts Univ. Diet Nutr. Let. November, pp. 3-5
Anon. (1998) FDA denies numerous structure/function claims. Food Regulation Weekly, Nov. 23, 1998
Arthur M & Courvalin P (1993) Genetics and mechanisms of glycopeptide resistance in enterococci. A minireview. Antimicrob. Agents Chemother. 37: 1563-1571
Arthur M, Reynolds P & Courvalin P (1996) Glycopeptide resistance in enterococci. Trends in Microbiol. 4: 401-407
Aso Y & Akazan H (1992) Prophylactic effect of Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP study group. Urol. Int. 49: 125-129
Berner LA & O'Donnell JA (1998) Functional foods and health claims legislations: applications to dairy foods. Int. Dairy J. 8: 355-362
Canganella F, Paganini S, Ovidi M, Vettraino AM, Bevilacqua L, Massa S & Trovatelli LD (1997) A microbiological investigation on probiotic pharmaceutical products used for human health. Microbiol. Res. 152: 171-179
Collins JK, Thornton G & Sullivan GO (1998) Selection of probiotic strains for human applications. Int. Dairy J. 8: 487-490
Donohue DC, Deighton M, Ahokas JT & Salminen S (1993) Toxicity of lactic acid bacteria. In: Salminen and von Wright (Eds.) Lactic Acid Bacteria, (pp 307-313). Marcel Dekker, Inc., New York
Dunne C, Murphy L, Flynn S, O'Mahony L, O'Halloran S, Feeney M, Morrisey D, Thornton G, Fitzgerald G, Daly C, Kiely B, Quigley EMM, O'Sullivan GC, Shanahan F & Collins JK (1999) Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. These proceedings.
Fonden R, Mogensen G, Tanaka R & Salminen S (1999) Effect of fermented dairy products on intestinal microflora, human nutrition and health: current knowledge and future perspectives. IDF Document. (In press)
Gasser F (1994) Safety of lactic acid bacteria and their occurrence in human clinical infections. Bull. Inst. Pasteur 92: 45-67
Giraffa G, Carminati D & Neviani E (1997) Enterococci isolated from dairy products: a review of risks and potential technological use. J. Food Protect. 60: 732-738
Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L & Salminen S (1992) Survival of Lactobacillus species (Strain GG) in human gastrointestinal tract. Dig. Dis. Sci. 37: 121-128
Guarner F & Schaafsma GJ (1998) Probiotics. Int. J. Food Microbiol. 39: 237-238
Hamilton-Miller JMT, Shah S & Smith CT (1996) 'Probiotic' remedies are not what they seem. Brit. Med. J. 312: 55-56
Hamilton-Miller JMT, Shah S & Winkler JT (1999) Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms. Public Health Nutr. (in press)
Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y & Takano T (1996) A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Amer. J. Clin. Nutr. 64: 767-771
Havenaar R & Huis in't Veld JHJ (1992) Probiotics: a general view. In: Wood BJB (Ed.) The lactic acid bacteria: Vol. I The lactic acid bacteria in health and disease. (pp 151-170). Elsevier Applied Science, London
Holzapfel WH, Haberer P, Snel J, Schillinger U & Huis in't Veld JHJ (1998) Overview of gut flora and probiotics. Int. J. Food Microbiol. 41: 85-101
Hosono A, Lee J, Ametani A, Natsume M, Hirayama M, Adachi T & Kaminogawa S (1997). Characterization of a water-soluble poly-saccharide fraction with immunopotentiating activity from Bifidobacterium adolescentis M101-4. Biosci. Biotech. Biochem. 61: 312-316
Huis in't Veld JHJ & Havenaar R (1997) Selection criteria and application of probiotic microorganisms in man and animal. Microecol. Ther. 26: 43-57
Jett BD, Huycke MM & Gilmore MS (1994) Virulence of enterococci. Clin Microbiol. Rev. 7: 462-478
Kampman E, Goldbohm RA, van den Brandt PA & van't Veer P (1994) Fermented dairy products, calcium and colorectal cancer in the Netherlands cohort study. Cancer Res. 54: 3186-3190
Kurtzweil P (1998) Staking a claim to good health. FDA and science stand behind health claims on foods. FDA Consumer, Nov-Dec. http://vm.cfsan.fda.gov/~dms/
Langseth L (1996) Nutritional epidemiology: possibilities and limitations. ILSI Press, Washington, DC
Maeno M, Yamamoto N & Takano T (1996) Identification of antihypertensive peptides from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 73: 1316-1321
Marin ML, Lee JH, Murtha J, Ustunol Z & Pestka JJ (1997) Differential cytokine production in clonal macrophage and T-cell lines cultured with bifidobacteria. J. Dairy Sci. 80: 2713-2720
Marteau P, Minekus M, Havenaar R & Huis in't Veld JHJ (1997) Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effect of bile. J. Dairy Sci. 80: 1031-1037
McNamara SH (1998) So you want to market a food and to make health-related claims — How far can you go? What rules of law will govern the claims you want to make? Food Drug Law J. 53: 421-436
Micanel N, Haynes IN & Playne MJ (1997) Viability of probiotic cultures in commercial Australian yogurts. Aust. J. Dairy Technol. 52: 24-27
Millar MR, Bacon C, Smith SL, Walker V & Hall MA (1993) Enteral feeding of premature infants with Lactobacillus GG. Arch. Dis. Childhood 69: 483-487
Minekus M, Smeets-Peeters M, Bernalier A, Marol S, Havenaar R, Marteau P, Alric M, Fonty G & Huis in't Veld JHJ (1999) A computer-controlled model of the large intestine with peristaltic mixing, absorption of fermentation products and a high-density microflora. (in press)
Minekus M, Marteau P, Havenaar R & Huis in't Veld JHJ (1995) A multicompartmental dynamic computer-controlled model simulating the stomach and small intestine. ATLA (Alternative To Laboratory Animals) 23: 197-209
Molin G, Jeppsson B, Johansson M-L, Ahrne S, Nobaek S, Stahl M & Bengmark S (1993) Numerical taxonomy of Lactobacillus spp. associated with healthy and diseased mucosa of the human intestines. J. Appl. Bacteriol. 74: 314-323
Monique GLe, Moulton LH, Hill C & Kramar A (1986) Consumption of dairy produce and alcohol in a case-control study of breast cancer. J. Nat. Cancer Instil. 77: 633-636.
Noble WC, Virani Z & Cree RGA (1992) Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 93: 195-198
Perdigon G, Nader de Macias ME, Alvarez S, Oliver G & Pesce de Ruiz Holgado AA (1986) Effect of perorally administered lactobacilli on macrophage activation in mice. Infect. Immun. 53: 404-410
Peters RK, Pike MC, Garabrant D & Mack TM (1992) Diet and colon cancer in Los Angeles County, California. Cancer Causes and Control 3: 457-473
Reuter G (1997) Present and future of probiotics in Germany and in Central Europe. Biosci. Microflora 16: 43-51
Roberfroid MB (1998) Prebiotics and synbiotics: concepts and nutritional properties. Brit. J. Nutr. 80: S197-S202
Salminen S, von Wright A, Morelli L, Marteau P, Brassart D, de Vos WM, Fonden R, Saxelin M, Collins K, Mogensen G, Birkeland S-E & Mattila-Sandholm T (1998). Demonstration of safety of probiotics — a review. Int. J. Food. Microbiol. 44: 93-106
Salminen S, Isolauri E & Salminen E (1996) Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains for future challenges. Antonie Van Leeuwenhoek 70: 347-358
Sanders ME (1998) Development of consumer probiotics for the US market. Brit. J. Nutr. 80: S213-S218
Sanders ME, Walker DC, Walker KM, Aoyama K & Klaenhammer TR (1996) Performance of commercial cultures in fluid milk applications. J. Dairy Sci. 79: 943-955
Savaiano DA, AbouElAnouar A, Smith DE & Levitt MD (1984) Lactose malabsorption from yogurt, pasteurized yogurt, sweet acidiohilus milk, and cultured milk in lactase-deficient individuals. Amer. J. Clin. Nutr. 40: 1219-1223
Saxelin M, (1997) Lactobacillus GG — a human probiotic strain with thorough clinical documentation. Food Rev. Int. 13: 293-313
Saxelin M, Rautelin H, Salminen S & Makela PH (1996a) Safety of commercial products with viable lactobacillus strains. Infect. Dis. Clin. Pract. 5: 331-335
Saxelin M, Chuang MH, Chassy B, Rautelin H, Makela PH, Salminen S & Gorbach SL (1996b) Lactobacilli and bacteremia in southern Finland, 1989-1992. Clin. Infect. Dis. 22: 564-566
Solis Pereyra B & Lemonnier D (1993) Induction of human cytokines by bacteria used in dairy foods. Nutr. Res. 13: 1127-1140
Spanhaak S, Havenaar R & Schaafsma G (1998) The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Europ. J. Clin. Nutr. 52: 899-907
Storlie J, O'Flaherty MJ & Hare K (1998) Food or Supplement? Choosing the appropriate regulatory path. Food Technol. 52: 62-69
Tannock GW (1999) Probiotics: A critical review. Horizon Press, Wymondham (Norfolk), UK
Tannock GW (1998) Studies of the intestinal microflora: a prerequisite for the development of probiotics. Int. Dairy J. 8: 527-533
Titze A, Kuhn C, Lorenz A, de Vrese M & Barth C (1996) The influence of viable lactobacilli on lactose degradation in the gut of gnotobiotic animals. XIIth International Symposium on Gnotobiology, Honolulu, pp. 43
Tomera JF (1996) Yogurt: probiotic pharmacology. Drugs of Today 32: 539-551
Tomioka H & Saito H (1992) Lactic acid bacteria in the support of immuno-compromised hosts. In: Wood BJB (Ed.) The lactic acid bacteria: Vol. I The lactic acid bacteria in health and disease. (pp 263-296) Elsevier Applied Science, London
van't Veer P, Dekker JM, Lamers JWJ, Kok FJ, Schouten EG, Brants HAM, Sturmans F & Hermus RJJ (1989) Cancer Res. 49: 4020-4023
Vesa TH, Marteau Ph, Zidi S, Briet F, Pochart Ph & Rambaud JC (1996) Digestion and tolerance of lactose from yoghurt and different semi-solid fermented dairy products containing Lactobacillus acidophilus and bifidobacteria in lactose maldigesters — Is bacterial lactase important? Euro. J. Clin. Nutr. 50: 730-733
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sanders, M.E., Huis in't Veld, J. Bringing a probiotic-containing functional food to the market: microbiological, product, regulatory and labeling issues. Antonie Van Leeuwenhoek 76, 293–315 (1999). https://doi.org/10.1023/A:1002029204834
Issue Date:
DOI: https://doi.org/10.1023/A:1002029204834